Loading…
Reported covered position: Policy Fellow, NIH/NHGRI, Office of the Director
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act No Bill#, America Competes Act, genetic testing
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2011 · second_quarter · 2T
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory-developed tests No Bill#, BETTER Patient Care Act Whole genome sequencing
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory developed tests Regulatory science No Bill#, BETTER Patient Care Act Whole genome sequencing
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Source: Senate LDA
| MEDCO HEALTH SOLUTIONS INC |
| 2 |
| 2009 |
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act H.R. 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R.3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010, Health care reform in general
America's Affordable Health Choices Act of 2009
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act H.R. 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R.3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010, Health care reform in general
America's Affordable Health Choices Act of 2009
Client: TETHYS BIOSCIENCE · Firm: HEALTHFUTURES, LLC
Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act H.R. 3962, Affordable Helath Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010 Regulation of laboratory developed tests.
Genomics and Personalized Medicine Act of 2010
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act
Genomics and Personalized Medicine Act of 2010
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza
Genomics and Personalized Medicine Act of 2010
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza No Bill#, BETTER Patient Care Act
Genomics and Personalized Medicine Act of 2010
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science No Bill#, BETTER Patient Care Act
Genomics and Personalized Medicine Act of 2010
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science
Genomics and Personalized Medicine Act of 2010
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act
Genomics and Personalized Medicine Act of 2010
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act
Genomics and Personalized Medicine Act of 2010
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Genomics and Personalized Medicine Act of 2010
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science
Strengthening America's Public Health System Act
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science
Strengthening America's Public Health System Act
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza No Bill#, BETTER Patient Care Act
Strengthening America's Public Health System Act
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza
Strengthening America's Public Health System Act
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science
Strengthening America's Public Health System Act
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Strengthening America's Public Health System Act
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Strengthening America's Public Health System Act
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine HR 3590, Patient Protection and Affordable Care Act, Pandemic influenza HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science
Strengthening America's Public Health System Act
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science No Bill#, BETTER Patient Care Act
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act No Bill#, America Competes Act, genetic testing
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act H.R. 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R.3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010, Health care reform in general
WMD Prevention and Preparedness Act of 2009
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza
American Middle Class Tax (AMT) Relief Act of 2007
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine HR 3590, Patient Protection and Affordable Care Act, Pandemic influenza HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act H.R. 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R.3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010, Health care reform in general
Superfund Polluter Pays Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act H.R. 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R.3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010, Health care reform in general
Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act H.R. 3962, Affordable Helath Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010 Regulation of laboratory developed tests.
To extend the temporary suspension of duty on certain nickel-metal hydride storage batteries designed for use in hybrid vehicles.
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act
To extend the temporary suspension of duty on certain nickel-metal hydride storage batteries designed for use in hybrid vehicles.
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act
To extend the temporary suspension of duty on certain nickel-metal hydride storage batteries designed for use in hybrid vehicles.
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act
To extend the temporary suspension of duty on certain nickel-metal hydride storage batteries designed for use in hybrid vehicles.
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; Health care reform in general Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Helath Care for America Act; H.R., Patient Protection and Affordable Care Act, Health care reform in general
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act
America's Affordable Health Choices Act of 2009
Client: TETHYS BIOSCIENCE · Firm: HEALTHFUTURES, LLC
Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act H.R. 3962, Affordable Helath Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act Regulation of laboratory deverloped tests.
America's Affordable Health Choices Act of 2009
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; Health care reform in general Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act
America's Affordable Health Choices Act of 2009
Client: TETHYS BIOSCIENCE · Firm: HEALTHFUTURES, LLC
Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act
America's Affordable Health Choices Act of 2009
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Helath Care for America Act; H.R., Patient Protection and Affordable Care Act, Health care reform in general
Food and Drug Administration Globalization Act of 2009
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
Pathogen detection S. 510, FDA Food Safety Modernization Act HR 759, Food and Drug Administration Globalization Act.
Food and Drug Administration Globalization Act of 2009
Client: LIFE TECHNOLOGIES · Firm: HEALTHFUTURES, LLC
Pathogen detection S 510, FDA Food Safety Modernization Act HR 759, Food and Drug Administration Globalization Act.
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Health Care Reform in general Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 16991/S 1220, Patient Access to Critical Lab Tests Act
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; Health care reform in general Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 16991/S 1220, Patient Access to Critical Lab Tests Act
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act
Patient Access to Critical Lab Tests Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Helath Care for America Act; H.R., Patient Protection and Affordable Care Act, Health care reform in general
Pathogen detection S. 510, FDA Food Safety Modernization Act HR 759, Food and Drug Administration Globalization Act.
Pathogen detection S 510, FDA Food Safety Modernization Act HR 759, Food and Drug Administration Globalization Act.
American Middle Class Tax (AMT) Relief Act of 2007
Client: TETHYS BIOSCIENCE · Firm: HEALTHFUTURES, LLC
Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act H.R. 3962, Affordable Helath Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act Regulation of laboratory deverloped tests.
Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act H.R. 3962, Affordable Helath Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act Regulation of laboratory deverloped tests.
Superfund Polluter Pays Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: HEALTHFUTURES, LLC
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Helath Care for America Act; H.R., Patient Protection and Affordable Care Act, Health care reform in general
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2011 · second_quarter · 2T
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#, Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act; No Bill#, BETTER Patient Care Act; HR 1249, American Invents Act
Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#, Genomics and Personalized Medicine Act; No Bill#, Genomic Research and Accessibility Act; No Bill#, BETTER Patient Care Act; HR 1249, America Invents Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), SENATE
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2011 · second_quarter · 2T
Oversight and regulation of genetic testing Direct to consumer genetic testing
Direct to consumer genetic testing
Oversight and regulation of genetic testing Direct to consumer genetic testing No Bill #, BETTER Patient Care Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2011 · second_quarter · 2T
Regulation of laboratory developed tests.
Issues relating to health care policy and the prevention of diabetes P.L. 111-148/P.L. 111-152, Affordable Care Act Regulation of laboratory developed tests.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2011 · first_quarter · Q1
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory developed tests Regulatory science No Bill#, BETTER Patient Care Act Whole genome sequencing
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory-developed tests No Bill#, BETTER Patient Care Act Whole genome sequencing
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2011 · first_quarter · Q1
Issues relating to health care policy and the prevention of diabetes P.L. 111-148/P.L. 111-152, Affordable Care Act Regulation of laboratory developed tests.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2011 · first_quarter · Q1
Oversight and regulation of genetic testing Direct to consumer genetic testing
Oversight and regulation of genetic testing Direct to consumer genetic testing No Bill #, BETTER Patient Care Act
Direct to consumer genetic testing
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2011 · first_quarter · Q1
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics No Bill#, Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act No Bill#, BETTER Patient Care Act
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2010 · fourth_quarter · Q4
Issues relating to health care policy and the prevention of diabetes P.L. 111-148/P.L. 111-152, Affordable Care Act Regulation of laboratory developed tests.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2010 · fourth_quarter · Q4
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues P.L. 111-148/P.L. 111-152, Affordable Care Act, health care reform in general
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), SENATE
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2010 · fourth_quarter · Q4
Oversight and regulation of genetic testing Direct to consumer genetic testing No Bill #, BETTER Patient Care Act
Oversight and regulation of genetic testing Direct to consumer genetic testing
Direct to consumer genetic testing
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2010 · fourth_quarter · Q4
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science No Bill#, BETTER Patient Care Act
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza No Bill#, BETTER Patient Care Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2010 · third_quarter · Q3
Issues relating to health care policy and the prevention of diabetes P.L. 111-148/P.L. 111-152, Affordable Care Act Regulation of laboratory developed tests.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2010 · third_quarter · Q3
Oversight and regulation of genetic testing Direct to consumer genetic testing No Bill #, BETTER Patient Care Act
Oversight and regulation of genetic testing Direct to consumer genetic testing
Direct to consumer genetic testing
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2010 · third_quarter · Q3
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues P.L. 111-148/P.L. 111-152, Affordable Care Act, health care reform in general
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), SENATE
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2010 · third_quarter · Q3
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS)
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2010 · second_quarter · Q2
Oversight and regulation of genetic testing Direct to consumer genetic testing No Bill #, BETTER Patient Care Act
Direct to consumer genetic testing
Oversight and regulation of genetic testing Direct to consumer genetic testing
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2010 · second_quarter · Q2
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues P.L. 111-148/P.L. 111-152, Affordable Care Act, health care reform in general
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), SENATE
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2010 · second_quarter · Q2
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2010 · second_quarter · Q2
Issues relating to health care policy and the prevention of diabetes P.L. 111-148/P.L. 111-152, Affordable Care Act Regulation of laboratory developed tests.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2010 · second_quarter · RA
Issues relating to legislative and regulatory oversight of direct-to-consumer genetic testing services.
Issues relating to legislative and regulatory oversight of direct-to-consumer genetic testing services.
Issues relating to legislative and regulatory oversight of direct-to-consumer genetic testing services.
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2010 · first_quarter · Q1
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine HR 3590, Patient Protection and Affordable Care Act, Pandemic influenza HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2010 · first_quarter · Q1
Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act H.R. 3962, Affordable Helath Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010 Regulation of laboratory developed tests.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2010 · first_quarter · Q1
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act No Bill#, America Competes Act, genetic testing
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act H.R. 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R.3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010, Health care reform in general
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), SENATE
MEDCO HEALTH SOLUTIONS, INC. via HEALTHFUTURES, LLC
2009 · third_quarter · RA
FDA approval of pharmaceutical products
INTERLEUKIN GENETICS via HEALTHFUTURES, LLC
2009 · fourth_quarter · Q4
P.L. 110-233, Genetic Information Nondiscrimination Act
P.L. 110-233, Genetic Information Nondiscrimination Act
P.L. 110-233, Genetic Information Nondiscrimination Act
Filing targets: Labor, Dept of (DOL)
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2009 · fourth_quarter · Q4
No bill#, Genomics and Personalized Medicine Act DNA patents
Personalized medicine Health Care Reform, Comparative effectiveness research Pandemic influenza Regulation of laboratory developed tests
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2009 · fourth_quarter · Q4
Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act H.R. 3962, Affordable Helath Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act Regulation of laboratory deverloped tests.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TESSARAE via HEALTHFUTURES, LLC
2009 · fourth_quarter · 4T
Issues relating to the use of advanced microbiology tests to monitor livestock for animal disease surveillance Pandemic influenza
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2009 · fourth_quarter · Q4
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; H.R. 3962, Affordable Helath Care for America Act; H.R., Patient Protection and Affordable Care Act, Health care reform in general
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2009 · third_quarter · Q3
HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; Health care reform in general Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), SENATE
TESSARAE via HEALTHFUTURES, LLC
2009 · third_quarter · Q3
Issues relating to the use of advanced microbiology tests to monitor livestock for animal disease surveillance Pandemic influenza
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2009 · third_quarter · Q3
Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2009 · third_quarter · Q3
Personalized medicine Health Care Reform, Comparative effectiveness research Pandemic influenza Regulation of laboratory developed tests
Pathogen detection S 510, FDA Food Safety Modernization Act HR 759, Food and Drug Administration Globalization Act.
No bill#, Genomics and Personalized Medicine Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via HEALTHFUTURES, LLC
2009 · third_quarter · RR
FDA approval of pharmaceutical products
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2009 · second_quarter · Q2
Pathogen detection S. 510, FDA Food Safety Modernization Act HR 759, Food and Drug Administration Globalization Act.
No bill#, Genomics and Personalized Medicine Act
Personalized medicine Health Care Reform, Comparative effectiveness research
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2009 · second_quarter · Q2
Health Care Reform in general Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 16991/S 1220, Patient Access to Critical Lab Tests Act
Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 16991/S 1220, Patient Access to Critical Lab Tests Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2009 · second_quarter · Q2
Issues relating to health care policy and the prevention of diabetes No bill #, Health Care Reform, prevention of Type 2 diabetes
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TESSARAE via HEALTHFUTURES, LLC
2009 · second_quarter · Q2
Issues relating to the use of advanced microbiology tests to monitor livestock for animal disease surveillance Pandemic influenza
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
INTERLEUKIN GENETICS via HEALTHFUTURES, LLC
2009 · second_quarter · Q2
Regulations impacting the implementation of the Genetic Nondiscrimination Information Act
Filing targets: Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Treasury, Dept of
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2009 · first_quarter · Q1
Issues relating to government oversight of direct-to-consumer genetic tests
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2009 · first_quarter · Q1
Issues relating to health care policy and the prevention of diabetes
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERLEUKIN GENETICS via HEALTHFUTURES, LLC
2009 · first_quarter · Q1
Regulations impacting the implementation of the Genetic Nondiscrimination Information Act
Filing targets: Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Treasury, Dept of
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2009 · first_quarter · Q1
Issues impacting the legislative and regulatory oversight of genetic and molecular tests
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2009 · first_quarter · Q1
Issues impacting the legislative and regulatory oversight of genetic testing
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TESSARAE via HEALTHFUTURES, LLC
2009 · first_quarter · Q1
Issues relating to the use of advanced microbiology tests to monitor livestock for animal disease surveillance
Filing targets: SENATE
LIFE TECHNOLOGIES via HEALTHFUTURES, LLC
2009 · second_quarter · RR
Issues related to the adoption of personalized medicine; food safety and testing; genomics research
Issues related to the adoption of personalized medicine; food safety and testing; genomics research
Issues related to the adoption of personalized medicine; food safety and testing; genomics research
INTERLEUKIN GENETICS via HEALTHFUTURES, LLC
2009 · first_quarter · RR
Regulations relating to the Genetic Information Nondiscrimination Act
Regulations relating to the Genetic Information Nondiscrimination Act
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2008 · fourth_quarter · Q4
Issues impacting the legislative and regulatory oversight of molecular diagnostics.
TESSARAE via HEALTHFUTURES, LLC
2008 · fourth_quarter · Q4
Issues related to the use of advanced microbiology tests to monitor livestock for food safety and annimal disease surveillance.
Filing targets: SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2008 · fourth_quarter · Q4
Issues related to health care policy and the prevention of diabetes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2008 · fourth_quarter · Q4
Issues related to government oversight of direct-to-consumer genetic testing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2008 · fourth_quarter · Q4
Issues related to the government oversight of direct-to-consumer tests
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2008 · third_quarter · Q3
Issues Impacting the Legislative & Regulatory Oversight of Molecular Diagnostics.
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2008 · third_quarter · Q3
Issues Related to Government Oversight of Direct-to-Consumer Genetic Tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TESSARAE via HEALTHFUTURES, LLC
2008 · third_quarter · Q3
Issues Related to the Use of Advanced Microbiology Tests to Monitor Livestock and For Food Safety & Animal Disease Surveillance.
Filing targets: SENATE
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2008 · third_quarter · Q3
Issues Relating To Health Care Policy on Prevention of Diabetes
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2008 · third_quarter · RR
Issues impacting the legislative & regulatory oversight of molecular diagnostics.
Issues impacting the legislative & regulatory oversight of molecular diagnostics.
Issues impacting the legislative & regulatory oversight of molecular diagnostics.
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2008 · third_quarter · RR
Legislation impacting reimbursement for diagnostic tests and for screening and prevention measures impacting Diabetes patients.
Legislation impacting reimbursement for diagnostic tests and for screening and prevention measures impacting Diabetes patients.
Legislation impacting reimbursement for diagnostic tests and for screening and prevention measures impacting Diabetes patients.
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2008 · third_quarter · RR
Issues relating to legislative & regulatory oversight of direct-to-consumer genetic tests.
Issues relating to legislative & regulatory oversight of direct-to-consumer genetic tests.
Issues relating to legislative & regulatory oversight of direct-to-consumer genetic tests.
ASSOCIATION FOR MOLECULAR PATHOLOGY via HEALTHFUTURES, LLC
2008 · third_quarter · RR
Issues impacting the legislative & regulatory oversight of molecular diagnostics.
Issues impacting the legislative & regulatory oversight of molecular diagnostics.
Issues impacting the legislative & regulatory oversight of molecular diagnostics.
TETHYS BIOSCIENCE via HEALTHFUTURES, LLC
2008 · third_quarter · RR
Legislation impacting reimbursement for diagnostic tests and for screening and prevention measures impacting Diabetes patients.
Legislation impacting reimbursement for diagnostic tests and for screening and prevention measures impacting Diabetes patients.
Legislation impacting reimbursement for diagnostic tests and for screening and prevention measures impacting Diabetes patients.
NAVIGENICS, INC. via HEALTHFUTURES, LLC
2008 · third_quarter · RR
Issues relating to legislative & regulatory oversight of direct-to-consumer genetic tests.
Issues relating to legislative & regulatory oversight of direct-to-consumer genetic tests.
Issues relating to legislative & regulatory oversight of direct-to-consumer genetic tests.
TESSARAE via HEALTHFUTURES, LLC
2008 · third_quarter · RR
Issues relating to the use of advanced microbiology tests in livestock testing, food safety, human & animal disease surveillance.
Issues relating to the use of advanced microbiology tests in livestock testing, food safety, human & animal disease surveillance.
Issues relating to the use of advanced microbiology tests in livestock testing, food safety, human & animal disease surveillance.
Issues related to the adoption of personalized medicine; food safety and testing; genomics research
Issues impacting the legislative & regulatory oversight of molecular diagnostics.
Issues relating to legislative & regulatory oversight of direct-to-consumer genetic tests.
Issues impacting the legislative & regulatory oversight of molecular diagnostics.
Issues relating to legislative & regulatory oversight of direct-to-consumer genetic tests.
Issues relating to the use of advanced microbiology tests in livestock testing, food safety, human & animal disease surveillance.
Issues relating to the use of advanced microbiology tests in livestock testing, food safety, human & animal disease surveillance.